SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Goedert JJ. Infectious causes of cancer: targets for intervention I. Totowa, NJ: Humana Press. 2000.
  • 2
    Chindamo MC, Spector N, Segadas JA, Pimenta G, Vanderborght B, Morais JC, Moraes Coelho HS. Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphomas. Oncol Rep 2002; 9: 6579.
  • 3
    Kallinowski B, Muller HM, Solbach C, Goeser T, Kabelitz D, Theilmann L. Hepatis C virus RNA in different blood lymphocyte subjects. Eur J Gastroenterol Hepatol 1994; 6: 24952.
  • 4
    Kuniyoshi M, Nakamuta M, Sakai H, Enjoji M, Kinukawa N, Kotoh K, Fukutomi M, Yokota M, Nishi H, Iwamoto H, Uike N, Nishimura J, et al. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol 2001; 16: 2159.
  • 5
    Montella M, Crispo A, de Bellis G, Izzo F, Frigeri F, Ronga D, Spada O, Mettivier V, Tamburini M, Cuomo O. HCV and cancer: a case-control study in a high-endemic area. Liver 2001; 21: 33541.
  • 6
    Sanchez Ruiz A, Yebra Bango M, Portero F, Provencio Pulla M, Miralles Flores C, España Saz P. Prevalencia de infeccion por el virus de la hepatitis C en pacientes con linfomas no hodgkinianos. Med Clin 2001; 116: 3334.
  • 7
    Zignego AL, Ferri C, Giannini C, La Civita L, Careccia G, Longombardo G, Bellesi G, Caracciolo F, Thiers V, Gentilini P. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. Arch Virol 1997; 142: 54555.
  • 8
    Ohsawa M, Shingu N, Miwa H, Yoshihara H, Kubo M, Tsukuma H, Teshima H, Hashimoto M, Aozasa K. Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection. Int J Cancer 1999; 80: 2379.
  • 9
    Carli PM, Jootse V, Guyen X, Minello A, Maynadie M, Hillon P. Association between Hepatitis C and Non Hodgkin lymphoma. Blood 2003; 100: 773a.
  • 10
    Rabkin CS, Tess BH, Christianson RE, Wright WE, Waters DJ, Alter HJ, Van Den Berg BJ. Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia. Blood 2002; 99: 42402.
  • 11
    Diamondstone LS, Aledort LM, Goedert JJ. Factors predictive of death among HIV-uninfected persons with haemophilia and other congenital coagulation disorders. Haemophilia 2002; 8: 6607.
  • 12
    Rabkin CS, Hilgartner MW, Hedberg KW, Aledort LM, Hatzakis A, Eichinger S, Eyster ME, White GC, Kessler CM, Lederman MM. Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia. JAMA 1992; 267: 10904.
  • 13
    Engels EA, Frisch M, Lubin JH, Gail MH, Biggar RJ, Goedert JJ. Prevalence of hepatitis C virus infection and risk for hepatocellular carcinoma and non-Hodgkin lymphoma in AIDS. J Acquir Immune Defic Syndr 2002; 31: 53641.
  • 14
    Dominguez A, Bruguera M, Vidal J, Plans P, Salleras L. Community-based seroepidemiological survey of HCV infection in Catalonia, Spain. J Med Virol 2001; 65: 68893.
  • 15
    Matutes E, Owusu-Ankomah K, Morilla R, Garcia MJ, Houlihan A, Que TH, Catovsky D. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8: 16405.
  • 16
    Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.
  • 17
    Colin C, Lanoir D, Touzet S, Meyaud-Kraemer L, Bailly F, Trepo C. Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature. J Viral Hepat 2001; 8: 8795.
  • 18
    Mele A, Pulsoni A, Bianco E, Musto P, Szklo A, Sanpaolo MG, Iannitto E, De Renzo A, Martino B, Liso V, Andrizzi C, Pusterla S, et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 2003; 102: 9969.
  • 19
    Zuckerman E. Hepatitis C infection and B-cell non-Hodgkin's lymphoma. Clin Lymphoma 2002; 3: 1612.
  • 20
    Sung VM, Shimodaira S, Doughty AL, Picchio GR, Can H, Yen TS, Lindsay KL, Levine AM, Lai MM. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 2003; 77: 213446.
  • 21
    Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S. Binding of hepatitis C virus to CD81. Science 1998; 282: 93841.
  • 22
    Fearon DT, Carter RH. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol 1995; 13: 12749.
  • 23
    Zignego AL, Ferri C, Giannelli F, Giannini C, Caini P, Monti M, Marrocchi ME, Di Pietro E, La Villa G, Laffi G, Gentilini P. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 2002; 137: 57180.
  • 24
    Zuckerman E, Zuckerman T, Sahar D, Streichman S, Attias D, Sabo E, Yeshurun D, Rowe JM. The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 2001; 97: 15559.
  • 25
    Hermine O, Lefrere F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, Delmas B, Valensi F, Cacoub P, Brechot C, Varet B, Troussard X. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 8994.
  • 26
    Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, Russo D, Falasca E, Botta GA, Baccarani M. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4296301.
  • 27
    Luppi M, Ferrari MG, Torelli G. Hepatitis C virus genotype distribution in B-cell non-Hodgkin lymphoma. Ann Intern Med 1998; 128: 602.
  • 28
    Viguier M, Bachelez H, Brice P, Rivet J, Dubertret L. [Cutaneous B-cell lymphoma treatment with rituximab: two cases]. Ann Dermatol Venereol 2002; 129: 11525.
  • 29
    Tursi A, Brandimante G, Chiarelli F, Spagnoli A, Torello M. Detection of HCV RNA in gastric mucosa-associated lymphoid tissue by in situ hybridization: evidence of a new extrahepatic localization of HCV with increased risk of gastric malt lymphoma. Am J Gastroenterol 2002; 97: 18026.
  • 30
    De Vita S, Sansonno D, Dolcetti R, Ferraccioli G, Carbone A, Cornacchiulo V, Santini G, Crovatto M, Gloghini A, Dammacco F. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995; 86: 188792.
  • 31
    Silvestri F, Barillari G, Fanin R, Pipan C, Falasca E, Salmaso F, Zaja F, Infanti L, Patriarca F, Botta GA, Baccarani M. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas. Haematologica 1997; 82: 3147.
  • 32
    Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol 2000; 13: 193207.
  • 33
    Nowak P, Schvarcz R, Ericzon BG, Flamholc L, Sonnerborg A. Follow-up of antiretroviral treatment in liver transplant recipients with primary and chronic HIV type 1 infection. AIDS Res Hum Retroviruses 2003; 19: 139.
  • 34
    Prachalias AA, Pozniak A, Taylor C, Srinivasan P, Muiesan P, Wendon J, Cramp M, Williams R, O'Grady J, Rela M, Heaton ND. Liver transplantation in adults coinfected with HIV. Transplantation 2001; 72: 16848.
  • 35
    Hezode C, Duvoux C, Germanidis G, Roudot-Thoraval F, Vincens AL, Gaulard P, Cherqui D, Pawlotsky JM, Dhumeaux D. Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation. Hepatology 1999; 30: 7758.
  • 36
    Zein NN, Perez RG, Wiesner RH. Hepatitis C virus infection and lymphoproliferative disorders after liver transplantation. Hepatology 2000; 31: 8089.
  • 37
    Alvarez M, Oyonarte S, Rodriguez PM, Hernandez JM. Estimated risk of transfusion-transmitted viral infections in Spain. Transfusion 2002; 42: 9948.